Listing Performance
▲ 38.95%
Issue Price
₹43
Listing Price
₹60
Listed On
19 May 2026
- Price Band
- ₹41 – ₹43
- Lot Size
- 3000
- Lot Value
- ₹1,29,000
- Open Date
- 12 May 2026
- Close Date
- 14 May 2026
- Min Investment
- ₹1,29,000
IPO Timeline
Issue Opens
12 May 2026 · Tue
Issue Closes
14 May 2026 · Thu
Bidding Cut-off (UPI Mandate)
14 May 2026 · 5:00 PM IST
Allotment
15 May 2026 · Fri
Listing
19 May 2026 · Tue
📊 Algorithmic Score
Computed from issue structure — GMP, fresh issue %, OFS %, issue size
Why do these differ? The Algorithmic Score measures issue quality (structure, size, promoter commitment). The Demand Analysis measures investor interest signals (subscription, GMP, risks). A high-quality issue can still have unconfirmed demand — especially before subscription opens.
✍️ Demand & Risk Analysis
Based on market demand signals — subscription, GMP trend, risk factors
IPO Market Analysis
▲ Listed +39.0%Grey market premium is positive at +35%, but subscription data is not yet available so demand cannot be confirmed. A cautious, limited-data view — weigh the company fundamentals before applying.
Pre-listing prediction: NEUTRAL
IPO Details
| Registrar | Bigshare Services Pvt. Ltd. |
| Exchange | BSE SME |
| ISIN | — |
| Face Value | ₹10 |
| Issue Size | ₹12.00 Cr |
| Fresh Issue | — |
| OFS Size | — |
| Lead Managers | Cumulative Capital Pvt. Ltd. |
Company Fundamentals
Capital Structure
Capital structure not yet available.
Shareholding Pattern
Shareholding pattern not yet available.
Reservations & OFS
Reservation & OFS detail not yet available.
Board & Management
Board & management not yet available.
Industry & Market
Industry & market data not yet available.
Application Lot Sizes
Retail caps at ₹2,00,000 (13 lots here). S-HNI is ₹2L–₹10L, B-HNI is above ₹10L.
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 3,000 | ₹1,29,000 |
| Retail (max) | 13 | 39,000 | ₹16,77,000 |
| S-HNI (min) | 14 | 42,000 | ₹18,06,000 |
| S-HNI (max) | 66 | 1,98,000 | ₹85,14,000 |
| B-HNI (min) | 67 | 2,01,000 | ₹86,43,000 |
Registrar (RTA)
SEBI-registered Registrar & Transfer Agent — handles allotment and refunds.
Registrar:Bigshare Services Pvt. Ltd.→Lead Managers (BRLMs)
Click any merchant banker for their full IPO track record (positive listing rate, average gain, IPOs managed).
3-Year Financial Summary
Financial data not available yet.
Subscription Status
Subscription data will appear once bidding begins.
Allotment Statistics
Basis of Allotment
Category-wise subscription & allotment ratio
Recently Listed IPOs
| Company | Listed | Listing Gain |
|---|---|---|
| Crazy Snacks | 03 Jul 2026 | — |
| Dhanwel Hybrid Seeds | 02 Jul 2026 | — |
| Sri Priyanka Geo Commex | 02 Jul 2026 | — |
Related IPOs
Documents
Frequently Asked Questions
When is the Goldline Pharmaceutical IPO opening?
The Goldline Pharmaceutical IPO opens on 12 May 2026 and closes on 14 May 2026. Check this page for the latest updates as we refresh every 30 minutes.
What is the price band of the Goldline Pharmaceutical IPO?
The price band for the Goldline Pharmaceutical IPO is ₹41 to ₹43. The final price is announced after the book-building process and is confirmed before listing.
What is the lot size and minimum investment for the Goldline Pharmaceutical IPO?
The minimum lot size is 3000 shares with a minimum investment of ₹1,29,000. Retail investors can apply for up to the retail limit defined by SEBI.
What is the GMP of Goldline Pharmaceutical IPO today?
The latest Grey Market Premium for Goldline Pharmaceutical is ₹15 (+35.00%). GMP is unofficial data and is not a guarantee of listing price.
When will the Goldline Pharmaceutical IPO list on NSE and BSE?
The Goldline Pharmaceutical IPO is expected to list on 19 May 2026 on BSE SME. Actual listing day trading begins at the start of the normal market session.
How can I check the Goldline Pharmaceutical IPO allotment status?
The registrar for this IPO is Bigshare Services Pvt. Ltd.. You can check your allotment status on the registrar's portal using your PAN, application number, or DP ID. We link to the registrar directly on our allotment page after the allotment date.
Is the Goldline Pharmaceutical IPO a mainboard or SME issue?
Goldline Pharmaceutical is a SME IPO that will list on the NSE Emerge or BSE SME platform. SME IPOs require a minimum application value of one lakh rupees.
How do I apply for the Goldline Pharmaceutical IPO?
You can apply for the Goldline Pharmaceutical IPO through any SEBI-registered broker such as Zerodha, Upstox, or Angel One using UPI or ASBA. Use the Apply Now buttons on this page to go directly to the broker.
What is the expected listing price of Goldline Pharmaceutical IPO?
Based on the current GMP of ₹15, the expected listing price of Goldline Pharmaceutical is ₹58 (issue price ₹43 + GMP ₹15). Note that GMP is unofficial grey market data and actual listing price may differ.
Should I subscribe to Goldline Pharmaceutical IPO?
Based on our algorithmic analysis, Goldline Pharmaceutical IPO is rated NEUTRAL with medium confidence. Grey market premium is positive at +35%, but subscription data is not yet available so demand cannot be confirmed. A cautious, limited-data view — weigh the company fundamentals before applying. This is not investment advice — please read the DRHP and consult a financial advisor before investing.
Related Articles
How to Apply for IPO Online Through UPI in 2026 — Zerodha, Groww, Upstox Guide
Complete guide to applying for an IPO online in India 2026. Step-by-step instructions for Zerodha, Upstox, Angel One, and ASBA net banking.
Read more →
How-ToHow to Check IPO Allotment Status — All Registrar Portals Guide 2026
Step-by-step guide to check IPO allotment status on KFintech, MUFG Intime, Bigshare, BSE and NSE portals using PAN, application number or DP ID.
Read more →
How-ToIPO Allotment Process Explained — How Shares Are Distributed to Investors
Understand how IPO allotment works in India — the lottery system for retail, proportionate allotment for HNIs, QIB allocation, and what happens after allotment.
Read more →